Formulation and pharmacodynamic evaluation of meloxicam liquisolid compacts by Emmadi, Srujan K. et al.
1303ISSN 0326-2383
KEY WORDS: Analgesic, Anti-inflammatory, Dissolution efficiency, Liquisolid compacts, Meloxicam,
Polyethylene glycol 400. 
* Author to whom correspondence should be addressed. E-mail: vpreddyindia@ yahoo.com.
Latin American Journal of Pharmacy
(formerly Acta Farmacéutica Bonaerense)
Lat. Am. J. Pharm. 29 (8): 1303-10 (2010)
Original Article
Received: February 27, 2010
Revised version: March 21, 2010
Accepted: March 27, 2010
Formulation and Pharmacodynamic Evaluation
of Meloxicam Liquisolid Compacts
Srujan K. EMMADI, Krishna SANKA, Appa R. POTU, Raju JUKANTI,
Suresh BANDARI & Prabhakar R. VEERAREDDY *
Department of Pharmaceutics, St. Peter’s Institute of Pharmaceutical Sciences,
Warangal, Andhra Pradesh, India-506001.
SUMMARY. The purpose of this study was to improve the meloxicam dissolution rate through its formulation in-
to liquisolid compacts and then to evaluate the in vitro and in vivo performance of the prepared liquisolid com-
pacts. Dissolution efficiency, mean dissolution time and relative dissolution rate of liquisolid compacts were cal-
culated and compared to marketed formulation. The degree of interaction between the ME and excipients was
studied by differential scanning calorimetry and X-ray diffraction were used and results revealed that, there was
a loss of meloxicam crystallanity upon liquisolid formulation and almost molecularly dispersed state, which con-
tributed to the enhanced drug dissolution properties. The optimized liquisolid compact showed higher dissolution
rates and dissolution efficiency compared to commercial product. The analgesic and anti inflammatory response
of optimized liquisolid compact in Swiss albino mice and Wistar rats was found to be superior compared to the
marketed formulation. 
